KPX Lifescience.Co.Ltd (114450) — Cash Flow Reinvestment Rate
KPX Lifescience.Co.Ltd (114450) has a Cash Flow Reinvestment Rate of 0.23x as of September 2025, reinvesting ₩768.79 Million (capex ₩275.98 Million plus investments ₩492.81 Million) from operating cash flow of ₩3.33 Billion. Explore KPX Lifescience.Co.Ltd capital spending ratio to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
KPX Lifescience.Co.Ltd Cash Flow Reinvestment Rate (2014–2024)
Historical reinvestment intensity for KPX Lifescience.Co.Ltd across 10 annual periods. Also explore KPX Lifescience.Co.Ltd assets under control for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for KPX Lifescience.Co.Ltd (2014–2024)
Year-by-year capital reinvestment analysis for KPX Lifescience.Co.Ltd. For live market cap and broader valuation context, see KPX Lifescience.Co.Ltd (114450) total market value.
| Year | Reinvestment Rate | Total Reinvested (KRW) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 7.12x | ₩3.74 Billion | ₩525.49 Million | ₩462.71 Million | ▼ -67.0% |
| 2023 | 21.60x | ₩7.99 Billion | ₩370.02 Million | ₩475.02 Million | ▲ +106.6% |
| 2021 | 10.45x | ₩6.39 Billion | ₩611.38 Million | ₩3.44 Billion | ▲ +152.0% |
| 2020 | 4.15x | ₩7.89 Billion | ₩1.90 Billion | ₩2.67 Billion | ▲ +74.1% |
| 2019 | 2.38x | ₩10.11 Billion | ₩4.24 Billion | ₩3.60 Billion | ▲ +46.5% |
| 2018 | 1.63x | ₩8.75 Billion | ₩5.38 Billion | ₩7.49 Billion | ▲ +78.2% |
| 2017 | 0.91x | ₩5.19 Billion | ₩5.68 Billion | ₩4.31 Billion | ▲ +39.7% |
| 2016 | 0.65x | ₩4.62 Billion | ₩7.07 Billion | ₩1.60 Billion | ▲ +123.3% |
| 2015 | 0.29x | ₩1.64 Billion | ₩5.62 Billion | ₩526.82 Million | ▼ -27.8% |
| 2014 | 0.41x | ₩1.65 Billion | ₩4.09 Billion | ₩838.78 Million | — |